PRKN and Parkinson disease: Of these, the SOD mimetic M40403 shows neuroprotective potential and protects against cellular oxidative damage and compensates for the loss of cytosolic and mitochondrial SOD, improves locomotor behavior [198], and partially ameliorates PINK–1/Parkin phenotypes [199] in an in vivo model of PD.